["Materials and Methods", "Reagent Sourcing.", "Unguinol, leoidin, nornidulin, stictic acid, nidulin, lobaric acid, salazinic acid, penicillide, galbinic acid, 7-chlorofolipastatin, folipastatin, and psoromic acid were sourced from Cayman chemicals. Gangaleoidin, lecanoric acid, evernic acid, atranorin, dihydroatranorin, and fumarprotocetraric acid were sourced from Microsource Discovery Systems. Dinaciclib was sourced from MedChemExpress. Staurosporine was sourced from LC labs. All compounds were dissolved in DMSO and used without further purification.", "Strains and Fermentation Conditions.", "A. uvarum (CBS121591, Country of origin: Italy) was obtained from the Centraalbureau voor Schimmelcultures (CBS) fungal collection through the Westerdijk Fungal Biodiversity Institute. A. uvarum was grown on Difco\u2122 PDA (Potato Dextrose Agar) Plates from BD biosciences for activation. Strain TTI001159 (Phaeosphaeria sp.) was obtained through collaboration with the lab of Gerald Bills at the University of Texas Health Science Center. BgHX18 (pyrG89; pyroA4; nkuA::argB; riboB2; easA::CRISPR; tdiA::CRISPR; stcA::CRISPR,easb::pyrG89), bgHX16 (pyrG89; pyroA4; nkuA::argB; riboB2; easA::pyroA; tdiA::CRISPR; stcA::CRISPR), and bgHX17 (pyrG89; pyroA4; nkuA::argB; riboB2; easA::CRISPR; tdiA::CRISPR; stcA::CRISPR) are modified versions of A. nidulans A1145 purchased from the Fungal Genetics Stock Center and used for heterologous expression of genes from TTI001159. Escherichia coli strain DH10B was used for cloning. Saccharomyces cerevisiae strain JHY692 (MATa his3\u03941 leu2\u03940 ura3\u03940 met15\u03940 SAL1+ HAP1+ CAT5(91M) MIP1(661T) MKT1(30G) RME1(INS-308A) TAO3(1493Q) prb1\u0394 pep4\u0394 ADH2p-npgA-ACS1) was used for homologous recombination of DNA fragments to assemble the vectors used in heterologous expression.", "Plasmid Construction for Heterologous Expression in A. nidulans and A. uvarum.", "Plasmids for heterologous expression were constructed as described previously (46). Briefly, plasmids pHex315, pHex318, and pHex344 were used as vectors to insert genes which contain auxotrophic markers for riboflavin (riboB), uracil (pyrG), and pyridoxine (pyroA), respectively. All genes were designed as fully spliced sequences and ordered as gene fragments from Twist Bioscience. Plasmids pHex315, pHex318, and pHex344 contain auxotrophic markers for riboB, pyrG, and pyroA, respectively, and served as the backbone vectors for all plasmid assembly. Vectors were linearized by digestion with pacI, and gene fragments for assembly were generated as PCR products using synthetic gene fragments as templates and the primers defined in SI Appendix, Table S1. The plasmids described in SI Appendix, Table S2 were assembled by yeast homologous recombination by combining 0.05 pmol each of the prepared fragments and transforming them in JHY692 using the Frozen-EZ Yeast Transformation II Kit\u2122 (Zymo Research).", "Gene fragments for construction of gene knockouts and transcription factor overexpression strains in A. uvarum were amplified using PCR genomic DNA as a template. For transcription factor overexpression, rosH was cloned under the constitutive promoter, PcoxAN in the pHex385 backbone. The pHex385 backbone contains a hygromycin selectable marker (hph) and the AMA1 fungal origin of replication.", "Transformation and Heterologous Production in A. nidulans and A. uvarum.", "Spores of A. nidulans/A. uvarum were inoculated into 25 mL YG medium and incubated in stationary culture at 30 \u00b0C overnight. After incubation, the biomass was collected using sterilized tweezers and washed with 10 mL of water twice. The germlings were then transferred into 25 mL of digestion buffer (Supplementary methods) containing 3 g of VinoTaste\u00ae Pro (Novozymes) and 100 mg of Yatalase\u2122 Enzyme (Takara Bio Cat#T017). The digestion was incubated for 5 h at 30 \u00b0C and 80 rpm. The digestion mix was poured into a 50-mL conical tube and overlaid with 10 mL of 0.4 M ST Buffer (SI Appendix, Supplementary Methods) and centrifuged at 1,800 \u00d7 g for 15 min. The protoplasts were then removed from the interface of the two buffers and transferred to sterile tubes. The protoplasts were washed with 0.6 M KCl, collected by centrifugation (1,800 \u00d7 g for 10 min), and resuspended in Transformation Buffer (SI Appendix, Supplementary Methods). DNA was added to the transformation mix and incubated on ice for an hour. PEG solution (60% w/v PEG 3350, 50 mM CaCl2, and 50 mM Tris-HCl) was added to the protoplast solution and incubated at room temperature for 20 min. The cells were then plated onto solid SMM (with the addition of 100 \u00b5g/\u00b5L hygromycin for A. uvarum). After transformants appeared on the plates, the A. nidulans/A. uvarum spores were restreaked onto solid GMM production medium at 37 \u00b0C for 3 d. The spores were collected with 0.01% Tween 80 solution and transferred into liquid GMM media for metabolite production. A. uvarum strains were grown in a panel of 12 growth media (SI Appendix, Supplementary Methods).", "Sample Analysis of A. nidulans Transformants and A. uvarum Extracts.", "Strains were grown in 96 well deep well plates with 500 \u00b5L of media. A. nidulans was grown at 30 \u00b0C for 3 d and A. uvarum was grown at 30 \u00b0C for 7 d. The plate was then frozen and lyophilized. The samples were then resuspended in 1:1 MeOH and injected onto the LC-MS for analysis.", "Kinase Phylogeny and Structural Alignments.", "Kinase sequences were collected from UniProt (SI Appendix, Table S5), trimmed to include only the kinase domain in the alignment, and aligned using MAFFT v7 (https://mafft.cbrc.jp/alignment/server/) (47) using the default settings. The phylogenetic trees were reconstructed using the neighbor-joining method with 1,000 bootstrap replicates.", "Structural alignments between 1-bound CDK2 (PDB: 8OY2) and either dinaciclib-bound CDK2 (PDB: 4KD1), SU9516-bound CDK2 (PDB: 3PY0), CGP74514A-bound CDK2 (PDB: 6GUK), AZA-5438-bound CDK2 (PDB: 6GUH), purvalanol B-bound CDK2 (cyan; 1CKP), K03861-bound CDK2 (PDB: 5A14), AMPK\u03b11 (PDB: 4CFF), or CAMK4 (PDB: 2W4O) were generated using TM-align (48). The aligned structures were visualized using PyMOL (Schr\u00f6dinger).", "CDK2/Cyclin E1 ATPase Assay.", "Active CDK2/cyclin E1 complex (baculovirus expressed in sf9 insect cells), histone H1 (purified from calf thymus tissues), and the ADP-Glo reagents were purchased from Promega. Typical reactions (20 \u00b5L final volume) contained 15 nM active CDK2/cyclin E1 complex, 0.1 mg/mL histone H1, 150 \u00b5M ATP, 20 mM MgCl2, 0.1 mg/mL BSA, 50 \u03bcM Dithiotheritol (DTT), and 5% DMSO (\u00b1 inhibitor) in 40 mM TRIS buffer at pH 7.5. Following a 30-min preincubation of the enzyme and inhibitor in the reaction mixture at room temperature, reactions were initiated with the addition of ATP and histone H1. Kinase reactions were carried out at room temperature for 30 min before reactions were quenched with the addition of one volume of ADP-Glo\u2122 reagent (Promega). Following a 60-min incubation at room temperature to remove excess ATP, two volumes of Kinase Detection Reagent (Promega) were added to the sample. The luminescence signal was allowed to develop for 30 min before being measured on a Spark multimode plate reader (Tecan). The percent inhibition was calculated by the comparison of the signal to DMSO (0% inhibition) and 55 nM dinaciclib (100% inhibition) controls. IC50 values were calculated from the dose\u2013response curves using Prism 9 (four-parameter, variable slope).", "Tight binding inhibition assays were performed as above except that the concentration of active CDK2/cyclin E1 complex was varied.", "ADP-Glo Counter Screen.", "Reactions (20 \u00b5L) were performed with 140 \u00b5M ATP, 10 \u00b5M ADP, 20 mM MgCl2, 0.1 mg/mL BSA, 50 \u03bcM DTT, and 5% DMSO (\u00b1 inhibitor) in 40 mM TRIS buffer at pH 7.5. Following a 30-min preincubation of the mixture, the ADP levels were quantified using the ADP-Glo kinase detection assay described above.", "Mechanism of Inhibition Studies.", "Reactions (20 \u00b5L final volume) were performed with 5 nM active CDK2/cyclin E1 complex, 20 mM MgCl2, 0.1 mg/mL BSA, 50 \u03bcM DTT, and 5% DMSO (\u00b1 inhibitor) in 40 mM TRIS buffer at pH 7.5. ATP and inhibitor concentrations were varied. Following a 30-min preincubation of the enzyme, inhibitor, and ATP in buffer at room temperature, reactions were initiated with the addition of histone H1 peptide (Promega) to a final concentration of 0.19 mg/mL. Kinase reactions were carried out at room temperature for 40 min before reactions were quenched with the addition of one volume of ADP-Glo\u2122 reagent (Promega) reagent. Following a 60-min incubation at room temperature to remove excess ATP, two volumes of Kinase Detection Reagent (Promega) were added to the sample. The luminescence signal was allowed to develop for 30 min before being measured on a Spark multimode plate reader (Tecan). For each concentration of ATP, a DMSO control (0% inhibition) and a 5 \u00b5M 1 control (100% inhibition) were run. Samples were blanked to the 5 \u00b5M 1 control to account for the presence of contaminating ADP in the ATP stock. ADP levels in reactions were determined by the comparison of the blank-corrected samples to an ADP standard curve. IC50 values were calculated from the dose\u2013response curves using the variable slope (four-parameter) model in Prism 9. The Kiapp was calculated from the kinetic curves using the competitive inhibition model in Prism 9.", "Kinase Selectivity ATPase Assay.", "Active kinases and their corresponding substrates were sourced from Promega as part of the CMGC kinase (catalog number: V6856) and general kinase (catalog number: V6928) panels. Reactions (10 \u00b5L final volume) were performed according to the manufacturer\u2019s protocol with a 30-min compound preincubation with active kinase at room temperature in the reaction mixture. Reactions were initiated by the addition of ATP (10 \u00b5M final) and kinase substrate. Following a 60-min reaction at room temperature, reactions were quenched with the addition of one volume of ADP-Glo\u2122 reagent (Promega) reagent. Following a 60-min incubation at room temperature to remove residual ATP, two volumes of Kinase Detection Reagent (Promega) were added to the sample. The luminescence signal was allowed to develop for 30 min before being measured on a Spark multimode plate reader (Tecan). The percent inhibition was calculated by the comparison of the signal to DMSO (0% inhibition) and no-enzyme (100% inhibition) controls. IC50 values were calculated from the dose\u2013response curves using Prism 9 (four parameter, variable slope).", "NanoBRET CDK2/Cyclin E1 Intracellular Target Engagement Assay.", "NanoBRET was performed using the NanoBRET Target Engagement Intracellular Kinase Assay (Promega) in HEK293 cells (ATCC CRL-1573). HEK293 cells were cultured in Roswell Park Memorial Institute (RPMI) (Invitrogen) with 10% fetal bovine serum (FBS; Invitrogen). For transfection, HEK293 cells were trypsinized and resuspended in Opti-MEM I Reduced Serum, no phenol red medium (Invitrogen) with 1% FBS at a concentration of 2 \u00d7 105 cells/mL. Five hundred microliters of a 10 \u03bcg/mL solution of DNA was prepared by adding 1 \u03bcg/mL of CDK2-NanoLuc Fusion Vector (Promega; NV2781) to 9 \u03bcg/mL of CCNE1 Expression Vector (Promega; NV2641) in Opti-MEM I Reduced Serum, no phenol red media. Thirty microliters of FuGENE HD Transfection Reagent (Promega) was added to each milliliter of DNA mixture. The lipid-DNA mixture was incubated at room temperature for 20 min. Postincubation, 10 mL of cells was added to the lipid\u2013DNA mixture and plated in a 96-well clear bottom white plate (Corning 3903) at a concentration of 2 \u00d7 104 cells/well. Cells were incubated at 37 \u00b0C with 5% CO2 for 20 to 30 h.", "Posttransfection, the media were replaced with fresh Opti-MEM I Reduced Serum, no phenol red medium. NanoBRET Tracer reagent K-10 (NV2641) was added at a concentration of 50 \u03bcM (1% DMSO final) along with 0.2% DMSO (\u00b1 inhibitor). Plates were incubated at 37 \u00b0C with 5% CO2 for 2 h. Following incubation, plates were removed from the incubator and allowed to equilibrate to room temperature for 15 min. A 3\u00d7 Complete Substrate Plus Inhibitor Solution was made by adding 30 \u03bcL of NanoBRET Nano-Glo Substrate (Promega), 10 \u03bcL of Extracellular NanoLuc Inhibitor (Promega), and 4,960 \u03bcL of Opti-MEM reduced serum medium, no phenol red (Invitrogen). Fifty microliters of 3\u00d7 Complete Substrate Plus Inhibitor Solution was added to each well, and the BRET signals (450 nm donor emission; 610 nm acceptor emission) were read on a GloMax Discover plate reader (Promega). A raw BRET ratio was generated by dividing the acceptor emission value by the donor emission value for each sample and compared to DMSO (0% inhibition) and 10 \u00b5M dinaciclib (100% inhibition) controls. IC50 values were calculated from the dose\u2013response curves using Prism 9 (four-parameter, variable slope). Experiments were performed in triplicate with technical duplicates in each run.", "Cell Cycle Analysis Assay.", "HCT-116 (ATCC CCL-247) cells were grown in DMEM + GlutaMAX (Thermo Fisher Scientific 10566-016) supplemented with 10% FBS (Thermo Fisher Scientific 16140-071) at 37 \u00b0C with 5% CO2. For synchronization, cells were seeded in 96-well microtiter plates at a density of 1.5 \u00d7 105 cells/ml in DMEM + GlutaMAX supplemented with 0.5% FBS for 96 h. After 96 h, the media were replaced with DMEM + GlutaMAX with 10% FBS, and test compounds in DMSO were added. DMSO levels were normalized. Cells were incubated for 24 at 37 \u00b0C and 5% CO2. Two hours prior to harvest, 20 \u00b5M of EdU was added from the Click-iT Plus EdU Flow Cytometry Assay Kit (Thermo Fisher Scientific C10633) to the media and incubated at 37 \u00b0C and 5% CO2. After 2 h, the media were removed, and cells were washed once with PBS and trypsinized. Cells were collected in a v-bottom 96-well plate and spun at 300 g for 5 min and washed again with PBS. Cells were fixed and permeabilized with eBiosciences FoxP3/Transcription factor fixation kit (Thermo Fisher Scientific 00-5523-00) for 20 min. After fixation, cells were spun at 800 \u00d7 g and washed twice with permeabilization buffer. Click-iT Plus reaction cocktail was added and incubated for 30 min in the dark at room temperature. Cells were washed twice with permeabilization buffer and spun at 800 \u00d7 g. Cells were stained with pHH3 for 30 min in the dark at room temperature. Cells were washed twice with permeabilization buffer and spun at 800 \u00d7 g. FxCycle Violet (Thermo Fisher Scientific F10347) was added at a concentration of 1 \u00b5g/mL for 30 min at room temperature in the dark. After incubation, cells were immediately acquired on a MACSQuant 10 cytometer (Miltenyi). Analysis was performed with Flowjo (BD Biosciences). The Dean\u2013Jett Fox algorithm was used for cell cycle staging. P values were calculated using a two-way ANOVA with Sidak post hoc test in Prism 9. Experiments were performed in triplicate with technical duplicates in each run.", "CDK2 Crystallization.", "Recombinant human CDK2 was expressed with an N-terminal histidine tag in E. coli. Purification was performed by nickel affinity and size exclusion chromatography. Final protein was concentrated to 20 mg/mL in a buffer containing 20 mM Tris HCl pH 8.0, 150 mM NaCl, and 2mM DTT for crystallography. Apo crystals of CDK2 were grown by vapor diffusion at 4 \u00b0C, mixing equal volumes of protein and well solution (MES pH 7.0, PEG3350, ammonium acetate). Crystals grew within 3 to 5 d and were soaked with 1 at a final concentration of 10 mM overnight. Crystals were cryoprotected with 15% glycerol and flash-frozen in liquid nitrogen.", "Data of CDK2-1 crystal was collected at the SWISS LIGHT SOURCE (SLS, Villigen, Switzerland). Data were processed using the software autoPROC, XDS, and AIMLESS (49\u201353). The crystals belong to the space group P 21 21 21 with one monomer in the asymmetric unit. The phase information was obtained by molecular replacement, using the coordinates of a previously solved CDK2 structure as a search model. Subsequent model building and refinement were performed according to standard protocols with COOT (54) and the software package CCP4 (52), respectively. Model quality was evaluated with MolProbity (55). Data collection and refinement statistics are provided in Supplementary Information SI Appendix, Tables S6 and S7. The structure was visualized using PyMOL (Schr\u00f6dinger).", "Isolation of Compounds.", "Cultures were extracted by liquid:liquid extraction with 1 volume of ethyl acetate. After shaking for 2 h, extracts were filtered, and the organic phase was collected and dried. The crude extract was subjected to HPLC fractionation using a semipreparative Phenyl column (XBridge BEH Phenyl OBD, 10 \u00d7 250 mm, 5 \u00b5m), with a gradient method using 0.1% aqueous formic acid (A)/acetonitrile with 0.1% formic acid (B) at 4 mL/min (5% B for 1 min; 5 to 40% B in 3 min; 40 to 100% B in 10 min; hold 100% B for 7 min). The collected fractions were analyzed using liquid chromatography-high resolution mass spectrometry (LC-HRMS) using 0.1% aqueous formic acid (A)/acetonitrile with 0.1% formic acid (B) with a linear gradient of 12.5 to 100% B in 5 min, and desired fractions were pooled. They were further fractionated using a semipreparative C18 column (XBridge BEH Shield RP18 OBD, 10 \u00d7 250 mm, 10 \u03bcm) with gradient method (35% for 3 min; 35 to 75% in 41 min; 75 to 100% in 1 min; hold 100% for 6 min) using the same solvents as above, at 4 mL/min, yielding 1 (r.t. 14.2 min, 8.0 mg), 6 (r.t. 36.8 min, 4.2 mg), 7 (r.t. 27.2 min, 1.4 mg), 8 (r.t. 23.7 min, 1.2 mg), 10 (r.t. 17.8 min, 2.2 mg), 11 (r.t. 7.7 min, 2.3 mg), and 12 (r.t. 16.2 min, 2.0 mg).", "HPLC purifications were performed using a Thermo Vanquish Flex HPLC. HPLC-HRMS analyses were acquired using a Thermo Vanquish HPLC system coupled to a Q-Exactive Orbitrap high-resolution mass spectrometer at 120 K resolution for MS1 and 17.5 K resolution for MS/MS. For elucidation of chemical structures, 1D and 2D NMR spectra were obtained on Bruker AV600 spectrometer (1H 600 MHz, 13C 150 MHz) equipped with a BBO cryoprobe. Chemical shifts were referenced using the solvent peak or TMS (\u03b4 0)."]